3-methyl-4-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)isoxazol-5-amine, 95.0%, 250mg

3-(3-Phenoxyphenyl)propan-1-ol, 95%, 250mg

(1R,2R)-2-Phenylcyclopropanecarboxylic acid, 97%, 1g

2-amino-5,5,7,7-tetramethyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carbonitrile, 95.0%, 500mg

2,6-bis(hydroxymethyl)-p-cresol, min. 97%, 100 g, glass packaging

Single-use cuvettes PMMA, Macro, 2.5 to 4.5 ml, 100 Piece(s)

N-(4-(((4-(4-Methoxyphenyl)tetrahydro-2H-pyran-4-yl)methyl)carbamoyl)phenyl)furan-2-carboxamide, 98%, 50mg

1-(2-Methylphenoxy)-2-propanol>90.0%(GC)5g

2,4,5-Trifluorobenzoyl chloride, 99.0%, 5g

(1R,2R,3S,4S,5R,6S)-7-OXABICYCLO[4.1.0]HEPTANE-2,3,4,5-TETRAOL, 97%, 1g

BATIMASTAT, 95%, 50mg

2-Amino-4,4,4-trifluoro-butyric acid ethyl ester hydrochloride, 95%, 50mg

5-Formyl-1-methyl-1H-pyrrole-2-carbonitrile, 97%, 50mg